Isolated Limb Infusion as a Model to Test New Agents to Treat Metastatic Melanoma

Keywords

Medicine, Melanoma, Metastatic melanoma, Disease, Animal model

References

• Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or MelanomaMalcolm K. Jones, R. Marno, Hannah M. Buchanan‐Smith — 2002
• The role of B-RAF in melanomaVanessa C. Gray‐Schopfer, Silvy da Rocha Dias, Richard Marais — 2005
• Bevacizumab-Induced Alterations in Vascular Permeability and Drug Delivery: A Novel Approach to Augment Regional Chemotherapy for In-Transit MelanomaМария Борисовна Ворошилова — 2012
• Regional perfusion with cis-platinum and dacarbazine.Karl Reinhard Aigner, Pitt Hild, K. Henneking — 1983
• New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance.Timothy Spiro, L. Liu, Stanley Gerson — 2000
• Melphalan-induced up-regulation of B7–1 surface expression on normal splenic B cellsManjula Donepudi, Vladimir M. Jovasevic, Pradip Raychaudhuri — 2003
• Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activityMoulay A. Alaoui‐Jamali, L. Panasci, Grazia M. Centurioni — 2004
• Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic MelanomaC. Augustine, Seung‐Hyun Jung, A. Potti — 2008
• Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia.Einar K. Rofstad, Berit Mathiesen — 2010
• Treatment of Metastatic Melanoma: An OverviewShailender Bhatia, Scott S. Tykodi, John A. Thompson — 2009
• Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusionJohannes H. W. de Wilt, Timo L.M. ten Hagen, Gert De Boeck — 2000
• Src family kinases in tumor progression and metastasisJustin M. Summy, Gary E. Gallick — 2003
• Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione.Francis Ali‐Osman — 1989
• Involvement of the mismatch repair system in temozolomide-induced apoptosis.Stefania D’Atri, Lucio Tentori, Pedro Miguel Lacal — 1998
• High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.D Liénard, Patricia Ewalenko, Jean-Baptiste Delmotte — 1992
• Src kinases as therapeutic targets for cancerLori C. Kim, Lanxi Song, Eric B. Haura — 2009
• Dechlorination of L-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione content.Kayoko Suzukake, Barbara P. Vistica, David T. Vistica — 1983
• Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents.Mark J. Hickman, Leona D. Samson — 1999
• B7-2 expression on tumor cells is important for the acquisition of cytotoxic T lymphocyte activity by spleen cells from low-dose-melphalan-treated MOPC-315 tumor bearers via a mechanism that requires either B7-1 or B7-2 expression on host antigen-presenting cellsDorothy K. Sojka, Ross N. La Motte, Margalit B. Mokyr — 2000
• Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model.Scott T. Kelley, Chandrakala Menon, Donald G. Buerk — 2002

Cited by

• The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic OptionsEmmanuel Gabriel, Joseph J. Skitzki — 2015
• Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin DeficiencyAlisha M. Gruntman, Terence R. Flotte — 2015
• Regional aspects of melanoma diagnosis and treatmentAnnemarleen Huismans — 2015
• A Translational Pathway for Recombinant Adeno-Associated Virus Human Gene Therapy: From Target Identification and Animal Modeling of the Disease to Non-Human Primate and Human StudiesAlisha M. Gruntman — 2016
• Molecular Aspects of the Isolated Limb Infusion ProcedureJüri Teras, Michael J. Carr, Jonathan S. Zager — 2021
• A phase 1 study of intra-arterial CBL0137 in extremity melanomas and sarcomasJoseph J. Skitzki, Minhyung Kim, Daniel T. Fisher — 2025
• Isolated Limb Infusion for MelanomaG. Beasley, John T. Miura, J. Zager — 2020
• University of Groningen Regional aspects of melanoma diagnosis and treatmentAnna M. Huismans — 2018
• Hyperthermic Regional Perfusion for Melanoma of the LimbsD. S. Tyler, D. Fraker, H. Hoekstra — 2018
• Isolated Limb Infusion for MelanomaG. Beasley, John T. Miura, J. Zager — 2018
• Chapter 14 – Gene TherapyA. Turner — 2017

Related papers

• Genentech taps Affimed’s antibodiesRyan Cross — 2018
• KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIKDjayanti Sari — 2023
• Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoriaAbraham Dib, Luiz Bóro Puig, Décio Salvadori — 1988
• Epidermotropic metastatic malignant melanoma.David A. Mehregan, M T Bergeon, Darius Mehregan — 1995
• Analysis of BRAF Mutation in Primary and Metastatic MelanomaMassimo Libra, Grazia Malaponte, Patrick M. Navolanic — 2005
• [The Role of BRAF/MEK Inhibition in Metastatic Malignant Melanoma - a Case Study].Jindřich Kopecký, Ondřej Kubeček — 2016
• Animal model of intracutaneous melanoma.Norman Levine, Laurinda L. Queen, Alan A. Chalom — 1982
• Methods for subchoroidal implantation of Greene melanoma in rabbitsKeigo Shikishima — 2004
• Supplementary Figures S1-S2 from Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma MetastasesLei Xu, Steven S. Shen, Yujin Hoshida — 2023